Artificial intelligence for diagnosing seborrheic keratosis
Part of Skin clinical trials.
This trial uses artificial intelligence to help diagnose seborrheic keratosis, a common harmless skin growth. It aims to see if the AI can accurately identify these growths from skin samples, which could help doctors make faster and more reliable diagnoses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a skin sample that was already diagnosed as seborrheic keratosis.
- Your skin sample is well-stained and well-preserved so details are clear.
- Your skin sample is not damaged, faded, or missing pieces.
- Your original diagnosis must be clear and not uncertain.
- Your skin sample can be scanned into a computer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence (AI) to help doctors more accurately identify early-stage breast cancer from test results. It could lead to faster and more precise diagnosis, which may help you get the right treatment sooner.
This study is testing whether an artificial intelligence (AI) system can accurately diagnose basal cell carcinoma, a common type of skin cancer, from microscope slide images. If you have had a biopsy slide of a skin lesion that was already diagnosed as basal cell carcinoma, your sample might be used to help train or test the AI.
This study uses artificial intelligence (AI) to look at skin biopsy slides from people with mycosis fungoides, a type of skin lymphoma. The goal is to see if AI can help doctors diagnose this condition more accurately, which could lead to better and earlier treatment.
This study uses artificial intelligence to help diagnose pattern hair loss (also called androgenetic alopecia) from scalp images. It may help doctors identify the condition more accurately and is testing the AI tool on different types of patients.
This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.
This study uses artificial intelligence to analyze magnified skin images of basal cell carcinoma to predict the cancer's subtype and risk classification. It aims to improve diagnosis and treatment planning without additional procedures.
Hear when a new Artifical Intelligence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.